The Kung-Flu Weapon? - Granite Grok

The Kung-Flu Weapon?

A little more than 20 years ago, Ken Alibek, a defector from the Soviet Union, exposed the extensive biological warfare activities of the USSR in his book, Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World – Told from Inside by the Man Who Ran It. The book is a great, but scary, read.

According to Wikipedia, during his heyday as a Soviet bio-weapons designer, in the late 1970’s and 1980’s, Alibek oversaw projects that included weaponizing glanders and Marburg hemorrhagic fever, and that created Russia’s first tularemia bomb. Perhaps his signal accomplishment was the creation of a new “battle strain” of anthrax, known as “Strain 836”, later hailed by the Los Angeles Times as “the most virulent and vicious strain of anthrax known to man.”

In 1992, he defected to the United States; he later became an American citizen and made his living as a biodefense consultant, speaker, and entrepreneur. He had actively participated in the development of biodefense strategy for the U.S. government.

So, with this background, and with some fragmentary information about the existence of bioweapons (the “poor man’s A bomb”) research being conducted in China, is it unreasonable to posit that the current pandemic did not actually originate in the wet markets in Wuhan but rather in a Chinese bioweapons facility?

Released by sloppy practices or intentionally?

We will probably never know the full story unless we get a defector like Alibek from China.

However, the shortages in our supply chains of many items, not the least important of which are pharmaceuticals and their components that have been outsourced to China, will continue to exist and we will continue to be highly vulnerable as a society unless and until we stop outsourcing to China, bring manufacturing back to the US from China, and stop buying products manufactured in China. When our dollar flow to China starts drying up, perhaps their Communist Party will get the message.